The lessons of MMR

Lancet

Volumn 363, Issue 9411, 2004, Pages 747-749

  Horton, Richard ^a  

^a THE LANCET   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AUTISM; DISEASE ASSOCIATION; MASS IMMUNIZATION; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; PUBLISHING; QUALITATIVE RESEARCH; RISK ASSESSMENT; VACCINATION;

EID: 1542345698     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)15714-0     Document Type: Note

References (23)

1. Murch S.H., Anthony A., Cassen D.H., et al. Retraction of an interpretation. Lancet. 363:2004;750.
2. Wakefield A.J., Murch S.H., Anthony A., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 351:1998;637-641.
3. Horton R. A statement by the editors of The Lancet. Lancet. 363:2004;820-821.
4. Kanner L. Autistic disturbances of affective contact. Nervous Child. 2:1943;217-250.
5. Volkmar F.R., Pauls D. Autism. Lancet. 362:2003;1133-1141.
6. Goode E. Autism cases up; cause is unclear. New York Times Jan. 26:2004;A1.
7. Volkmar F.R., Cohen D.J. Disintegrative disorder or "late onset" autism. J Child Psychol Psychiatry. 30:1989;717-724.
8. MRC review of autism research: epidemiology and causes. London: MRC, 2001.
9. Farthing M., Horton R., Smith R. UK's failure to act on research misconduct. Lancet. 356:2000;2030.
10. Jefferson T., Price D., Demicheli V., et al. Unintended events following immunisation with MMR: a systematic review. Vaccine. 21:2003;3954-3960.
11. Jefferson T. Informed choice and balance are victims of the MMR-autism saga. Lancet Infect Dis. 4:2004;135-136.
12. Editorial. This orchestrated campaign must not be allowed to stifle real debate on MMR. The Independent Feb 24, 2004: 16.
13. Torrente F, Anthony A, Heuschkel RB et al. Focal enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacter pylori gastritis. Am J Gastroenterol (in press).
14. DeFelice M.L., Ruchelli E.D., Markowitz J.E., et al. Intestinal cytokines in children with pervasive developmental disorders. Am J Gastroenterol. 98:2003;1777-1782.
15. Shapin S. A social history of truth. 1995;University of Chicago Press, Chicago.
16. Roberts K.A., Dixon-Woods M., Fitzpatrick R., Abrams K.R., Jones D.R. Factors affecting uptake of childhood immunisation: a Bayesian synthesis of qualitative and quantitative evidence. Lancet. 360:2002;1596-1599.
17. Davidoff F., DeAngelis C.D., Drazen J.M., et al. Sponsorship, authorship, and accountability. Lancet. 358:2001;854-856.
18. James A., Horton R. The Lancet's policy on conflicts of interest. Lancet. 361:2003;8-9.
19. James A., Horton R., Collingridge D., McConnell J., Butcher J. The Lancet's policy on conflicts of interest - 2004. Lancet. 363:2004;2-3.
20. Editorial. Dissent must be aired. Times Higher Educational Supplement Feb 27, 2004: 14.
21. McBride W.G. Thalidomide and congenital abnormalities. Lancet. ii:1961;1358.
22. Calman K.C. Communication of risk: choice, consent, and trust. Lancet. 360:2002;166-168.
23. Anonymous. MMR vaccine - how effective and how safe? Drug Ther Bull 2003; 41: April, 1-6.